StockData
Ascendis Pharma A/S logo

Ascendis Pharma A/S (ASND) stock

ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 7/30
$271.19−0.54 (-0.20%)

Close on Nov 17, 2026Market cap $16.81BP/E 22.3Yield –

Ascendis Pharma A/S market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ascendis Pharma A/S's market cap was $16.52B on Nov 11, 2026, against $12.98B a year earlier. Over the last 5 years it ranged from $3.92B to $16.75B, with a median of $7.70B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$16.52B+26.7%
2025Dec 31, 2025$13.03B+63.4%
2024Dec 31, 2024$7.98B+12.8%
2023Dec 29, 2023$7.07B+2.8%
2022Dec 30, 2022$6.88B-10.1%
2021Dec 31, 2021$7.65B-14.1%
2020Dec 31, 2020$8.91B+34.1%
2019Dec 31, 2019$6.64B+152.2%
2018Dec 31, 2018$2.63B+147.5%
2017Dec 29, 2017$1.06B+121.2%
2016Dec 30, 2016$481.04M–

More Ascendis Pharma A/S figures

See a number that looks wrong?